查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587416

生物皮膚替代市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區、細分市場預測，2025-2030 年

Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

生物皮膚替代市場成長與趨勢

根據Grand View Research, Inc最新報告，預計到2030年，全球生物皮膚替代市場規模將達到57,908萬美元，2025年至2030年複合年成長率為8.88%。

皮膚病患病率的增加、慢性病和創傷性緊急情況的發病率增加以及對組織工程和潛在研發線產品的認知不斷增強是推動組織奈米轉染技術發展的一些關鍵因素。此外，政府和私人組織對研發活動的投資增加預計將推動對生物皮膚替代的需求。

虛擬助理的流行正在影響創傷護理過程的多個方面，包括創傷護理就診的遵守情況、虛擬護理平台和遠端醫療的使用，以及幫助患者進行傷口包紮的社會支持，例如媒體平台上的影片串流。引發了增強的自助傷口敷料方法。人們越來越渴望了解健康的社會方面如何影響創傷護理患者的生活品質 (QoL) 和結果。由於醫療保健領域的這些變化，創傷護理的連續性在多個方面受到了破壞。然而，這些變化不僅對傷口結果產生負面影響，而且還推動了開發基於虛擬的患者就診方法。

市場上的主要企業正在尋求透過升級產品、採取重大合作以及考慮收購和政府批准來改善其產品組合、擴大客戶群並佔領生物皮膚替代市場的更大佔有率。

生物皮膚替代市場報告亮點

  • 按類型分類，人類供體組織衍生產品細分市場佔據最大市場佔有率，2024 年將達到 67.42%。
  • 從應用來看，由於慢性傷口盛行率不斷增加，預計在預測期內，慢性傷口細分市場將以 9.13% 的複合年成長率成長最快。
  • 按最終用途分類，醫院細分市場在生物皮膚替代市場中佔據主導地位，到 2024 年，其銷售佔有率將達到 54.97%。由於等待時間減少和更靈活的調度選項，門診病人設施領域預計在預測期內的複合年成長率將達到 8.9%。
  • 由於該地區有主要企業的存在，2024 年北美地區的收益佔有率最大，接近 41.25%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 生物替代皮膚變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 生物替代皮膚分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章生物皮膚替代市場：細分分析，按類型，2018-2030（百萬美元）

  • 定義和範圍
  • 2024 年及 2030 年類型市場佔有率分析
  • 2018-2030 年全球生物皮膚替代市場（按類型）
  • 2018-2030年市場規模、預測與趨勢分析

第5章生物皮膚替代市場：細分分析，按應用，2018-2030（百萬美元）

  • 定義和範圍
  • 2024 年和 2030 年應用市場佔有率分析
  • 全球生物皮膚替代市場（按應用），2018-2030
  • 2018-2030年市場規模、預測與趨勢分析

第6章生物皮膚替代市場：細分分析，按最終用途，2018-2030（百萬美元）

  • 定義和範圍
  • 2024 年及 2030 年最終用途市場佔有率分析
  • 全球生物皮膚替代市場（按最終用途），2018-2030 年
  • 2018-2030年市場規模、預測與趨勢分析

第7章生物皮膚替代市場：區域、估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • Organogenesis Inc.
    • Integra LifeSciences Corporation
    • Smith+Nephew
    • Tissue Regenix
    • MIMEDX Group, Inc.
    • Essity Aktiebolag（publ）（Essity Health & Medical）
    • Stryker
    • Vericel Corporation
    • 3M
    • BioTissue
Product Code: GVR-4-68040-040-0

Biological Skin Substitutes Market Growth & Trends:

The global biological skin substitutes market size is expected to reach USD 579.08 million by 2030 and is expected to expand at a CAGR of 8.88% from 2025 to 2030 based on a new report by Grand View Research, Inc. The increasing prevalence of skin diseases, rising incidence of chronic diseases & trauma emergencies, and increasing consciousness regarding tissue engineering, along with potential pipeline products, are some of the major factors responsible for the growth of tissue nano transfection technology. Furthermore, increasing government and private organizations' investment in research and development activities is likely to boost the demand for biological skin substitutes.

The COVID-19 pandemic has affected several aspects of the wound care process, which includes compliance with wound care visits, triggering alternative approaches such as the use of virtual care platforms or telemedicine and streaming videos on the social media platform to assist the patients with wound dressing and empowering a do-it-yourself wound dressing approach. There is an increasing desire to understand how the social dimensions of health impact the Quality of Life (QoL) and effectiveness of wound care patients. The direct consequence of such changes in health care is the disruption of the continuity of wound care in several ways. However, these changes have negatively impacted wound outcomes but also have driven the development of a virtual-based approach for patient visits.

The key companies in the market are attempting to improve their portfolio by upgrading their products, employing significant cooperative efforts, and considering acquisitions and government permissions to increase their client base and capture a larger share of the biological skin substitutes market.

Biological Skin Substitutes Market Report Highlights:

  • Based on type, the human donor tissue-derived products segment accounted for the largest market share of 67.42% in 2024 as it allows better integration and acceptance by the patient's body
  • Based on application, the chronic wounds segment is expected to witness the fastest growth, with a CAGR of 9.13% over the forecast period due to the increasing prevalence of chronic wounds
  • Based on end-use, the hospital segment dominated the biological skin substitutes market with a revenue share of 54.97% in 2024. The outpatient facilities segment is expected to witness the fastest CAGR of 8.9% over the forecast period owing to the shorter wait times and more flexible scheduling options
  • North America accounted for the largest revenue share of nearly 41.25% in 2024 owing to the presence of major companies in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Applications
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Biological Skin Substitute Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Chronic Diseases
      • 3.2.1.2. Technological Advancements In Biological Skin Substitutes
      • 3.2.1.3. Rising Geriatric Population
      • 3.2.1.4. Increasing Surgical Procedures
      • 3.2.1.5. Growing Burn And Trauma Cases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost Of Skin Substitute Products
      • 3.2.2.2. Regulatory Hurdles
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Demand For Aesthetic Procedures
      • 3.2.3.2. Expansion In Emerging Markets
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Intense Competition
  • 3.3. Biological Skin Substitute Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Biological Skin Substitute Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Global Biological Skin Substitute Market, by Type, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Human Donor Tissue -derived Products
      • 4.4.1.1. Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
    • 4.4.2. Acellular Animal-derived Products
      • 4.4.2.1. Acellular Animal-derived Products, 2018 - 2030 (USD Million)

Chapter 5. Biological Skin Substitute Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Global Biological Skin Substitute Market, by Application, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Acute Wounds
      • 5.4.1.1. Acute Wounds market, 2018 - 2030 (USD Million)
    • 5.4.2. Chronic Wounds
      • 5.4.2.1. Chronic Wounds market, 2018 - 2030 (USD Million)

Chapter 6. Biological Skin Substitute Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2030
  • 6.3. Global Biological Skin Substitute Market, by End Use, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.4.1. Hospitals
      • 6.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
    • 6.4.2. Outpatient facilities
      • 6.4.2.1. Outpatient facilities market, 2018 - 2030 (USD Million)
    • 6.4.3. Research and manufacturing
      • 6.4.3.1. Research and manufacturing market, 2018 - 2030 (USD Million)

Chapter 7. Biological Skin Substitute Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Organogenesis Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Integra LifeSciences Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Smith+Nephew
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Tissue Regenix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. MIMEDX Group, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Essity Aktiebolag (publ))( Essity Health & Medical)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Stryker
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Vericel Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. 3M
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. BioTissue
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3 North America biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 5. North America biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 7. U.S. biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 8. U.S. biological skin substitute, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. biological skin substitute, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 12. Canada biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 15. Mexico biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 17. Europe biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 18. Europe biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 19. Europe biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 20. UK biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 21. UK biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 22. UK biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 24. Germany biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 25. Germany biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 26. France biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 27. France biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 28. France biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Italy biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 30. Italy biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 31. Italy biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Spain biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 33. Spain biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 34. Spain biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Norway biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 36. Norway biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 37. Norway biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Sweden biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 39. Sweden biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 40. Sweden biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Denmark biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 42. Denmark biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 43. Denmark biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 48. China biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 49. China biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 50. China biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Japan biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 51. Japan biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 53. Japan biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 54. India biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 55. India biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 56. India biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 57. Australia biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 58. Australia biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 59. Australia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 60. South Korea biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 61. South Korea biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 62. South Korea biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 63. Thailand biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 64. Thailand biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 65. Thailand biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Latin America biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 67. Latin America biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 68. Latin America biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 69. Latin America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Brazil biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 71. Brazil biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 72. Brazil biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 73. Argentina biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 74. Argentina biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 75. Argentina biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 77. Middle East & Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 78. Middle East & Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 80. South Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 81. South Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 82. South Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 86. UAE biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 87. UAE biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 88. UAE biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 89. Kuwait biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 90. Kuwait biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 91. Kuwait biological skin substitute market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Disposable Syringes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biological Skin Substitutes Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 15 Global Biological Skin Substitutes Market, for Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
  • Fig. 16 Global Biological Skin Substitutes Market, for Acellular Animal-derived Products, 2018 - 2030 (USD Million)
  • Fig. 17 Global Biological Skin Substitutes Market, for Applications, 2018 - 2030 (USD Million)
  • Fig. 18 Global Biological Skin Substitutes Market, for Acute Wounds, 2018 - 2030 (USD Million)
  • Fig. 19 Global Biological Skin Substitutes Market, for Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 20 Global Biological Skin Substitutes Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 21 Global Biological Skin Substitutes Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 22 Global Biological Skin Substitutes Market, for Outpatient Facilities, 2018 - 2030 (USD Million)
  • Fig. 23 Global Biological Skin Substitutes Market, for Research and manufacturing, 2018 - 2030 (USD Million)
  • Fig. 24 Regional Outlook, 2023 & 2030
  • Fig. 25 North America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 32 France Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait Biological Skin Substitutes Market, 2018 - 2030 (USD Million)